Resources

Publications

07/22/2024
- Oncology
Dynamic Changes in Circulating Tumor Fraction as a Predictor of Real-World Clinical Outcomes in Solid Tumor Malignancy Patients Treated with Immunotherapy
Oncology and Therapy
07/17/2024
- Cardiology
Accelerated Cardiac Magnetic Resonance Imaging Using Deep Learning for Volumetric Assessment in Children
Pediatric Radiology
07/11/2024
- Oncology
Concordance Analysis of Tissue and Circulating Tumor DNA (ctDNA) in Renal Cell Carcinoma (RCC): Insights from a Multimodal Real-World Database
KCRS 2024
06/29/2024
- Oncology
Noninterventional Cohort Study of Biomarker Testing and Treatment Patterns in Patients With Advanced Gastric or Gastroesophageal Junction (G/GEJ) Cancer
ESMO GI 2024
05/23/2024
- Oncology
Prognostic value of PORTEC-3 molecular markers by disease risk in a real-world early endometrial cancer cohort
ASCO 2024
05/23/2024
- Oncology
Prognostic impact of BRCA mutation on metastasis-free survival in a localized/locoregional high-risk real-world prostate cancer population
ASCO 2024
05/23/2024
- Oncology
Cost-effectiveness of a circulating tumor fraction molecular biomarker for treatment response monitoring
ASCO 2024
05/23/2024
- Oncology
Characterization of DNA damage repair (DDR) alterations and the tumor immune microenvironment (TIME) in advanced non-small cell lung cancer (NSCLC)
ASCO 2024
05/23/2024
- Oncology
Longitudinal clinical performance of a novel tumor-naive minimal residual disease assay in patients with resected stage II and III colorectal cancer: A subset analysis from the GALAXY study in CIRCULATE-Japan
ASCO 2024
05/23/2024
- Oncology
Changes in non-small cell lung cancer (NSCLC) next-generation sequencing (NGS) rates after electronic health record (EHR) integration using large-scale, multi-institutional, real-world data
ASCO 2024

18 19 20